These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 17572714)

  • 1. Microbial contamination of hematopoietic progenitor cell products: clinical outcome.
    Patah PA; Parmar S; McMannis J; Sadeghi T; Karandish S; Rondon G; Tarrand J; Champlin R; de Lima M; Shpall EJ
    Bone Marrow Transplant; 2007 Aug; 40(4):365-8. PubMed ID: 17572714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microbial contamination of hematopoietic stem cell products: incidence and clinical sequelae.
    Klein MA; Kadidlo D; McCullough J; McKenna DH; Burns LJ
    Biol Blood Marrow Transplant; 2006 Nov; 12(11):1142-9. PubMed ID: 17085307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microbial contamination of hematopoietic progenitor cell products.
    Namdaroğlu S; Tekgündüz E; Bozdağ SC; Durgun G; Sarıca A; Demiriz IŞ; Koçubaba S; Iskender G; Kayıkçı O; Altuntaş F
    Transfus Apher Sci; 2013 Jun; 48(3):403-6. PubMed ID: 23664302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microbial contamination of hematopoietic progenitor cell grafts-incidence, clinical outcome, and cost-effectiveness: an analysis of 735 grafts.
    Kamble R; Pant S; Selby GB; Kharfan-Dabaja MA; Sethi S; Kratochvil K; Kohrt N; Ozer H
    Transfusion; 2005 Jun; 45(6):874-8. PubMed ID: 15934984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of pulsed-field gel electrophoresis to identify the source of bacterial contamination of peripheral blood progenitor cell products.
    Reich-Slotky R; Wu F; Della-Latta P; Savage DG; Schwartz J
    Transfusion; 2008 Nov; 48(11):2409-13. PubMed ID: 18657076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autologous transplant: microbial contamination of hematopoietic stem cell products.
    Almeida ID; Schmalfuss T; Röhsig LM; Goldani LZ
    Braz J Infect Dis; 2012; 16(4):345-50. PubMed ID: 22846122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of harvest bacterial contamination on autologous peripheral blood progenitor cells post-transplant.
    Majado MJ; García-Hernández A; Morales A; González C; Martínez-Sánchez V; Menasalvas A; Rosique P; Rubio A; Sanz-Imedio E
    Bone Marrow Transplant; 2007 Jan; 39(2):121-5. PubMed ID: 17173054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sterility testing of hematopoietic progenitor cell products: a single-institution series of culture-positive rates and successful infusion of culture-positive products.
    Padley DJ; Dietz AB; Gastineau DA
    Transfusion; 2007 Apr; 47(4):636-43. PubMed ID: 17381622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microbial contamination of peripheral blood stem cell collections.
    Attarian H; Bensinger WI; Buckner CD; McDonald DL; Rowley SD
    Bone Marrow Transplant; 1996 May; 17(5):699-702. PubMed ID: 8733684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microbial contamination of cellular products for hematolymphoid transplantation therapy: assessment of the problem and strategies to minimize the clinical impact.
    Lowder JN; Whelton P
    Cytotherapy; 2003; 5(5):377-90. PubMed ID: 14578100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality control of bacterial contamination in autologous peripheral blood stem cells for transplantation.
    Larrea L; de la Rubia J; Soler MA; Ribas P; Fernández JM; Picón I; García-Boyero R; García-Bellés C; Roig R
    Haematologica; 2004 Oct; 89(10):1232-7. PubMed ID: 15477209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microbial contamination of hematopoietic progenitor and other regenerative cells used in transplantation and regenerative medicine.
    Jacobs MR; Good CE; Fox RM; Roman KP; Lazarus HM
    Transfusion; 2013 Nov; 53(11):2690-6. PubMed ID: 23461309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microbial contamination of BM products before and after processing: a report of incidence and immediate adverse events in 257 grafts.
    Vanneaux V; Foïs E; Robin M; Rea D; de Latour RP; Biscay N; Chantre E; Robert I; Wargnier A; Traineau R; Benbunan M; Marolleau J; Socié G; Larghero J
    Cytotherapy; 2007; 9(5):508-13. PubMed ID: 17786612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How much GMP do we need to infuse contaminated HPC and DLI products?
    Forte L; Gardiner N; O'Connell B; McCann SR
    Bone Marrow Transplant; 2007 Aug; 40(4):389-90. PubMed ID: 17572717
    [No Abstract]   [Full Text] [Related]  

  • 15. What is the clinical significance of infusing hematopoietic cell grafts contaminated with bacteria?
    Kelly M; Roy DC; Labbe AC; Laverdiere M
    Bone Marrow Transplant; 2006 Aug; 38(3):183-8. PubMed ID: 16785868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microbial contamination of harvested bone marrow and peripheral blood.
    Prince HM; Page SR; Keating A; Saragosa RF; Vukovic NM; Imrie KR; Crump M; Stewart AK
    Bone Marrow Transplant; 1995 Jan; 15(1):87-91. PubMed ID: 7742761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does microbial contamination influence the success of the hematopoietic cell transplantation outcomes?
    Dal MS; Tekgündüz E; Çakar MK; Kaya AH; Namdaroğu S; Batgi H; Bekdemir F; Uncu Ulu B; Yiğenoğlu TN; Kılınç A; İskender D; Uğur B; Koçubaba Ş; İskender G; Altuntaş F
    Transfus Apher Sci; 2016 Aug; 55(1):125-8. PubMed ID: 27184293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Favorable outcome after infusion of coagulase-negative staphylococci-contaminated peripheral blood hematopoietic cells for autologous transplantation.
    Nifong TP; Ehmann WC; Mierski JA; Domen RE; Rybka WB
    Arch Pathol Lab Med; 2003 Jan; 127(1):e19-21. PubMed ID: 12562288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Occurrence and severity of adverse events after autologous hematopoietic progenitor cell infusion are related to the amount of granulocytes in the apheresis product.
    Calmels B; Lemarié C; Esterni B; Malugani C; Charbonnier A; Coso D; de Colella JM; Deconinck E; Caillot D; Viret F; Ladaique P; Lapierre V; Chabannon C
    Transfusion; 2007 Jul; 47(7):1268-75. PubMed ID: 17581163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of bacteremia in patients undergoing hematopoietic stem cell transplantation.
    Castagnola E; Faraci M
    Expert Rev Anti Infect Ther; 2009 Jun; 7(5):607-21. PubMed ID: 19485800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.